1. Home
  2. UTSI vs CASI Comparison

UTSI vs CASI Comparison

Compare UTSI & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTSI
  • CASI
  • Stock Information
  • Founded
  • UTSI 1991
  • CASI 1991
  • Country
  • UTSI China
  • CASI China
  • Employees
  • UTSI N/A
  • CASI N/A
  • Industry
  • UTSI Telecommunications Equipment
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTSI Telecommunications
  • CASI Health Care
  • Exchange
  • UTSI Nasdaq
  • CASI Nasdaq
  • Market Cap
  • UTSI 24.9M
  • CASI 20.5M
  • IPO Year
  • UTSI 2000
  • CASI 1996
  • Fundamental
  • Price
  • UTSI $2.49
  • CASI $1.63
  • Analyst Decision
  • UTSI
  • CASI Strong Buy
  • Analyst Count
  • UTSI 0
  • CASI 1
  • Target Price
  • UTSI N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • UTSI 4.8K
  • CASI 3.4M
  • Earning Date
  • UTSI 09-04-2025
  • CASI 08-19-2025
  • Dividend Yield
  • UTSI N/A
  • CASI N/A
  • EPS Growth
  • UTSI N/A
  • CASI N/A
  • EPS
  • UTSI N/A
  • CASI N/A
  • Revenue
  • UTSI $10,878,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • UTSI N/A
  • CASI N/A
  • Revenue Next Year
  • UTSI N/A
  • CASI N/A
  • P/E Ratio
  • UTSI N/A
  • CASI N/A
  • Revenue Growth
  • UTSI N/A
  • CASI 8.39
  • 52 Week Low
  • UTSI $1.84
  • CASI $1.09
  • 52 Week High
  • UTSI $3.22
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • UTSI 48.18
  • CASI 53.72
  • Support Level
  • UTSI $2.19
  • CASI $1.25
  • Resistance Level
  • UTSI $2.50
  • CASI $2.57
  • Average True Range (ATR)
  • UTSI 0.08
  • CASI 0.25
  • MACD
  • UTSI -0.01
  • CASI 0.03
  • Stochastic Oscillator
  • UTSI 68.18
  • CASI 30.37

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: